Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6111]

ASCO 2023: Extended lymph node removal does not benefit patients with clinically localised muscle-invasive bladder cancer

ASCO 2023: Extended lymph node removal does not benefit patients with clinically localised muscle-invasive bladder...

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

Scientists identify how some angiogenic drugs used to treat cancer and heart disease cause vascular disease

Pan-cancer T cell atlas reveals new details of tumour microenvironment

Pan-cancer T cell atlas reveals new details of tumour microenvironment

A metabolic process in cancer cells could unlock a possible treatment for glioblastoma

A metabolic process in cancer cells could unlock a possible treatment for glioblastoma

Blocking a key immune protein improves radiation therapy for cancer

Blocking a key immune protein improves radiation therapy for cancer

ASCO 2023: US-Mexico cross-border collaboration greatly improves paediatric leukaemia survival

ASCO 2023: US-Mexico cross-border collaboration greatly improves paediatric leukaemia survival

Blocking a key immune protein improves radiation therapy for cancer

Blocking a key immune protein improves radiation therapy for cancer

ASCO 2023: Adding pembrolizumab to chemotherapy improves survival in people with advanced cervical cancer

ASCO 2023: Adding pembrolizumab to chemotherapy improves survival in people with advanced cervical cancer 

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

ASCO 2023: Luspatercept enables majority of patients with MDS to end reliance on blood transfusions

ASCO 2023: Luspatercept enables majority of patients with MDS to end reliance on blood transfusions

More from ecancer